Celularity Announces Multiple Presentations at the American Association for Cancer Research (AACR) Annual Meeting 2021

NEXT STORY
Signature Resources Provides a Project Update on Ongoing Drilling Activities at Its 100% Owned Lingman Lake Gold Project
PREV STORY
Surface Oncology Presents Promising Preclinical Data for Lead Immunotherapy Product Candidates at the American Association for Cancer Research Annual Meeting
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

FDA grants accelerated approval for ADUHELM™ as the first and only Alzheimer’s disease treatment to address a defining pathology of the disease

author_avatar
NASDAQ Market News

Sandoz and Pear Therapeutics announce launch of reSET® for treatment of patients with Substance Use Disorder

reSET® is the first and only FDA-authorized prescription digital therapeutic for Substance Use Disorder ...

author_avatar
NASDAQ Market News

RespireRx Pharmaceuticals Inc. Executives Presenting at the International Cannabinoid Derived Pharmaceuticals Summit

December 11 – 12, 2018 Workshops, December 10, 2018 The Revere Hotel 200 Stuart ...

author_avatar
NASDAQ Market News